| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | +1.4% | +0.4% |
| R&D Expense | $1.1M | -8.9% | -1.4% |
| SG&A Expense | $8.7M | +3.1% | -5.9% |
| Operating Income | -$9.1M | -114.9% | -228.9% |
| Pre-tax Income | -$8.7M | -114.2% | -215.7% |
| Income Tax | -$2.1M | -127.3% | -776.9% |
| Net Income | -$6.6M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.5M | -24.4% | +2.6% |
| Current Assets | $50.1M | -14.9% | +24.3% |
| Total Assets | $417.0M | -0.8% | +27.6% |
| Current Liabilities | $36.0M | +4.0% | +47.6% |
| Total Liabilities | $181.1M | +0.6% | -0.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.0M | — | — |
| Capital Expenditures | $9K | — | — |
| Investing Cash Flow | -$5.6M | — | — |
| Financing Cash Flow | -$1.6M | — | — |
| Free Cash Flow | -$10.0M | — | — |
| -112.3% |
| -185.6% |
| EPS (Basic) | -$0.35 | -112.2% | -185.4% |
| EPS (Diluted) | -$0.35 | -112.2% | -185.4% |
| $236.0M |
| -1.8% |
| +63.0% |